The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets

被引：0
|
作者：
Torsten Lowin
Georg Pongratz
Rainer H. Straub
机构：
[1] University Hospital Duesseldorf,Funktionsbereich & Hiller Forschungszentrum für Rheumatologie, Life Science Center
[2] University Hospital of Regensburg,Laboratory of Experimental Rheumatology and Neuroendocrine Immunology
来源：
Journal of Inflammation | / 13卷
关键词：
Cannabinoid; Synovial fibroblasts; Cytokines; MMP; Proliferation; Arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 14 条
  • [1] The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets
    Lowin, Torsten
    Pongratz, Georg
    Straub, Rainer H.
    JOURNAL OF INFLAMMATION-LONDON, 2016, 13
  • [2] The synthetic cannabinoid and CB1/CB2 agonist WIN55212,2 decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating TRPV1 and non-cannabinoid receptor targets
    Lowin, Torsten
    Graeber, Angelika
    Straub, Rainer H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 833 - 833
  • [3] The Endocannabinoid Anandamide Modulates Adhesion, Proliferation and The Production Of Inflammatory Mediators In Rheumatoid Arthritis Synovial Fibroblasts By Activating CB1, TRPV1, TRPA1 and Non-Cannabinoid Receptor Targets
    Lowin, Torsten
    Graeber, Angelika
    Straub, Rainer H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S398 - S399
  • [4] ANTIINFLAMMATORY ACTIVITY OF WIN55,212-2, A NONSELECTIVE CANNABINOID CB1/CB2 RECEPTOR AGONIST
    Bradley, Jennifer
    Wang Yanyan
    Jankovic, Lazar
    Huang, Iris
    Sharma, Esha
    Moore, Christine
    Peberdy, Mary
    Ornato, Joseph
    Tang, Wanc-Hun
    Zhou, Huiping
    CRITICAL CARE MEDICINE, 2020, 48
  • [5] The endocannabinoid anandamide modulates adhesion, proliferation and the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB1, TRPV1 and non-cannabinoid receptor targets
    Lowin, T.
    Graeber, A.
    Straub, R.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 106 - 106
  • [6] Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
    Sheng, WS
    Hu, SX
    Min, XN
    Cabral, GA
    Lokensgard, JR
    Peterson, PK
    GLIA, 2005, 49 (02) : 211 - 219
  • [7] WIN55,212-2 via CB2 receptor attenuates TNF-α and ROS in RAW264.7 macrophages by activating ERK1/2 signaling
    Hao, Ming-Xiu
    Jiang, Li-Sheng
    Fang, Ning-Yuan
    He, Ben
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S6 - S6
  • [8] Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement
    Spyridakos, Dimitris
    Papadogkonaki, Sofia
    Dionysopoulou, Stavroula
    Mastrodimou, Niki
    Polioudaki, Hara
    Thermos, Kyriaki
    NEUROCHEMISTRY INTERNATIONAL, 2021, 142
  • [9] Capsazepine, a Transient Receptor Potential Vanilloid Type 1 (TRPV1) Antagonist, Attenuates Antinociceptive Effect of CB1 Receptor agonist, WIN55,212-2, in the Rat Nucleus Cuneiformis
    Parvishan, Asghar
    Taslimi, Zahra
    Ebrahimzadeh, Mohammad
    Haghparast, Abbas
    BASIC AND CLINICAL NEUROSCIENCE, 2011, 2 (04) : 19 - 26
  • [10] Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner
    Torsten Lowin
    Martin Apitz
    Sven Anders
    Rainer H. Straub
    Arthritis Research & Therapy, 17
12